Correlation of serum levels of HIF-1α and IL-19 with the disease progression of COPD: a retrospective study

References

• HalpinDMMiravitllesMMetzdorfNCelliBImpact and prevention of severe exacerbations of COPD: a review of the evidenceInt J Chron Obstruct Pulmon Dis2017122891290829062228
   PubMed Web of Science ®Google Scholar
• CortopassiFGurungPPinto-PlataVChronic obstructive pulmonary disease in elderly patientsClin Geriatr Med201733453955228991649
   PubMed Web of Science ®Google Scholar
• ZinelluEZinelluAFoisAGCarruCPirinaPCirculating biomarkers of oxidative stress in chronic obstructive pulmonary disease: a systematic reviewRespir Res201617115027842552
   PubMed Web of Science ®Google Scholar
• AdcockIMMarwickJCasolariPMechanisms of corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD)Curr Pharm Des201016323554357320977420
   PubMed Web of Science ®Google Scholar
• BarnesPJCellular and molecular mechanisms of asthma and COPDClin Sci2017131131541155828659395
   PubMed Web of Science ®Google Scholar
• BarnesPJInflammatory mechanisms in patients with chronic obstructive pulmonary diseaseJ Allergy Clin Immunol20161381162727373322
   PubMed Web of Science ®Google Scholar
• CaramoriGCasolariPBarczykADurhamALdi StefanoAAdcockICOPD immunopathologySemin Immunopathol201638449751527178410
   PubMed Web of Science ®Google Scholar
• SandauKBZhouJKietzmannTBrüneBRegulation of the hypoxia-inducible factor 1 alpha by the inflammatory mediators nitric oxide and tumor necrosis factor-alpha in contrast to desferroxamine and phenylarsine oxideJ Biol Chem200127643398053981111514583
   PubMed Web of Science ®Google Scholar
• YuZGWangBZChengZZThe association of genetic polymorphisms of hypoxia inducible factor-1 alpha and vascular endothelial growth factor with increased risk of chronic obstructive pulmonary disease: A case–control studyKaohsiung J Med Sci201733943344128865600
   PubMed Web of Science ®Google Scholar
• MizunoSBogaardHJGomez-ArroyoJMicroRNA-199a-5p is associated with hypoxia-inducible factor-1α expression in lungs from patients with COPDChest2012142366367222383663
   PubMed Web of Science ®Google Scholar
• JiangHZhuYXuHSunYLiQActivation of hypoxia-inducible factor-1 alpha via nuclear factor-kappa B in rats with chronic obstructive pulmonary diseaseActa Biochim Biophys Sin201042748348820705587
   PubMedGoogle Scholar
• LinJRQinHHWangYLiangJXuJHJhXAnalysis of interleukin 19 serum levels and single nucleotide polymorphisms in systemic lupus erythematosusGenet Mol Res2016152
   Web of Science ®Google Scholar
• LiLZheng-QingYJuan-YuHAssociation between interleukin-19 and angiopoietin-2 with vascular complications in type 2 diabetesJ Diabetes Investig201676895900
   PubMed Web of Science ®Google Scholar
• HoriuchiHParajuliBWangYInterleukin-19 acts as a negative autocrine regulator of activated microgliaPLoS ONE2015103e011864025794104
   PubMed Web of Science ®Google Scholar
• LiaoYCLiangWGChenFWHsuJHYangJJChangMSIL-19 induces production of IL-6 and TNF-alpha and results in cell apoptosis through TNF-alphaJ Immunol200216984288429712370360
   PubMed Web of Science ®Google Scholar
• Montes de OcaMLópez VarelaMVLaucho-ContrerasMEClassification of patients with chronic obstructive pulmonary disease according to the Latin American Thoracic Association (ALAT) staging systems and the global initiative for chronic obstructive pulmonary disease (GOLD)Arch Bronconeumol20175339810627956034
   PubMed Web of Science ®Google Scholar
• VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
   PubMed Web of Science ®Google Scholar
• VogelmeierCFCrinerGJMartinezFJGlobal strategy for the diagnosis, management and prevention of chronic obstructive lung disease 2017 report: GOLD Executive SummaryRespirology201722357560128150362
   PubMed Web of Science ®Google Scholar
• JainSSelfWHWunderinkRGCommunity-acquired pneumonia requiring hospitalization among U.S. adultsN Engl J Med2015373541542726172429
   PubMed Web of Science ®Google Scholar
• BellingerCRPetersSPOutpatient chronic obstructive pulmonary disease management: going for the GOLDJ Allergy Clin Immunol Pract20153447147826164571
   PubMed Web of Science ®Google Scholar
• LaunoisCBarbeCBertinEThe modified Medical Research Council scale for the assessment of dyspnea in daily living in obesity: a pilot studyBMC Pulm Med2012126123025326
   PubMed Web of Science ®Google Scholar
• LisspersKLarssonKJohanssonGEconomic burden of COPD in a Swedish cohort: the ARCTIC studyInt J Chron Obstruct Pulmon Dis20181327528529391785
   PubMed Web of Science ®Google Scholar
• CaramoriGAdcockIMdi StefanoAChungKFCytokine inhibition in the treatment of COPDInt J Chron Obstruct Pulmon Dis2014939741224812504
   PubMed Web of Science ®Google Scholar
• Baz-DávilaREspinoza-JiménezARodríguez-PérezMCRole of HIF1A, VEGFA and VEGFR2 SNPs in the susceptibility and progression of COPD in a Spanish populationPLoS ONE2016115e015499827163696
   PubMed Web of Science ®Google Scholar
• FujimotoYFujitaTKuramotoNThe role of interleukin-19 in contact hypersensitivityBiol Pharm Bull201841218218929386478
   PubMed Web of Science ®Google Scholar
• ZhongHWuYBelardinelliLZengDA2B adenosine receptors induce IL-19 from bronchial epithelial cells, resulting in TNF-alpha increaseAm J Respir Cell Mol Biol200635558759216778150
   PubMed Web of Science ®Google Scholar
• HuangWCWuMFChenHCHsuJYTOLD GroupFeatures of COPD patients by comparing CAT with mMRC: a retrospective, cross-sectional studyNPJ Prim Care Respir Med2015251506326538368
   PubMed Web of Science ®Google Scholar
• KimSOhJKimYIDifferences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analysesBMC Pulm Med2013133523731868
   PubMed Web of Science ®Google Scholar